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aortic transection
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Rhee, MD, Michel S. Makaroun, MD, and Jae-Sung Cho, MD, Pittsburgh, Pa
Background: Traumatic transection of the thoracic aorta is a highly morbid injury. Treatment may be delayed while
attention focuses on concomitant injuries. Thoracic endovascular aortic repair (TEVAR) is effective but remains
controversial in these often-young patients. We reviewed our experience in acute and subacute treatment of these injuries
with TEVAR.
Methods: A retrospective analysis of five men and five women who underwent TEVAR for aortic transection from 1999 to
2007 was conducted. Procedures were performed with standard endovascular techniques. Follow-up included computed
tomography at 1 month and yearly thereafter.
Results: Mean age was 44 years (range, 20 to 84 years). Motor vehicle accidents accounted for 7 injuries, a snowmobile
accident for 1, skydiving for 1, and balloon angioplasty of a coarctation for 1. Average diameter of the proximal landing
zone was 25 mm (range, 23 to 29 mm). Mean external iliac size was 10 mm (range, 7 to 15 mm), and no conduits were
required. Immediate technical success was 90%, with no 30-day mortality. Seven patients underwent repair acutely (<24
hours) and three patients subacutely (range, 4 days to 2 months) for pseudoaneurysm. Four patients had procedures for
concomitant injuries before their transection was repaired (3 laparotomies and a fixation for open fracture). One endoleak
was noted, which resolved by the 1-month follow-up. The lone device-related complication was an endograft collapse at
5 months managed by repeat endografting, which was complicated by aortoesophageal fistula requiring esophagectomy
and open reconstruction. No iliac injuries occurred. At 20-months of mean follow-up (range, 2 to 70 months), all patients
are alive and well.
Conclusions: TEVAR for traumatic aortic transection is feasible, with good initial success. Repair can be delayed in selected
cases. Continued surveillance is necessary to ensure good long-term outcomes in these young patients. Care must be taken
when performing TEVAR for this off-label indication because these devices are designed for the larger aortic diameters
of aneurysm patients. ( J Vasc Surg 2007;46:928-33.)Traumatic thoracic aortic transection (TAT) carries an
overall mortality of 90%.1 More than 80% of patients with
this injury die at the scene of the accident, and of those who
do reach a hospital, a 1% mortality per hour has been
described.1 Delay in treatment for this injury is sometimes
necessary while diagnostic and management efforts focus
on other injuries. In some cases, initially unrecognized
transections can progress to chronic contained perforations
with ongoing risk of rupture.
The main mechanism of injury in TAT is movement of
the mobile aortic arch against the fixed proximal descend-
ing thoracic aorta during deceleration injury, such as in a
motor vehicle accident or a fall.2 In fact, 15% of all deaths
from motor vehicle accidents are thought to result from
aortic injury, second only to the 60% caused by head
injury.3
For nearly 50 years, open repair of TAT has been the
standard of care for this injury.4 Unfortunately, this treat-
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928ment can be lengthy, requires a thoracotomy with aortic
cross-clamping, and incurs its own significant risks, which
often can be prohibitive in patients with associated head,
abdominal, and orthopedic injuries. Operative mortality
can be as high as 28%, and paraplegia affects up to 14% of
patients after surgery.5
Repair of these injuries with thoracic aortic stent grafts
promises to offer a lower risk alternative to open surgery for
these patients. Several case reports and small series of
patients with TAT treated in the acute setting with stent
grafts have described acceptable technical success, compli-
cation, and mortality rates.6-10 In theory, the avoidance of
a thoracotomy and aortic cross-clamping should decrease
complication and death rates after aortic repair in these
complex, critically ill patients.
This study reports our experience in the endovascular
repair of TAT performed in the acute setting as well as the
subacute repair of contained pseudoaneurysms after treat-
ment of other injuries.
PATIENTS AND METHODS
A retrospective review was conducted of all patients
who underwent endovascular repair of TAT performed by
the Division of Vascular Surgery at the University of Pitts-
burgh Medical Center between December 1999 and Janu-
ary 2007. Institutional Review Board approval for this
study was obtained. Study variables analyzed included age,
sex, mechanism of injury, associated injuries, time elapsed
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graft, stent graft–associated complications, and mortality.
All radiographic imaging was reviewed to identify the
method of diagnosis, to obtain morphologic information
about the aortic transection, and to measure aortic and
external iliac artery diameters.
In acute settings, standard advanced trauma life sup-
port protocols were used to assess patients, and life-
threatening injuries such as intraperitoneal hemorrhage
were addressed first. Then the transection repair was per-
formed by using a Cook Zenith TX2 TAA Endovascular
Graft (Cook Inc, Bloomington, Ind) or a Gore TAG Tho-
racic Endoprosthesis (W. L. Gore & Associates Inc, Flag-
staff, Ariz) as described previously.11 Gore Excluder exten-
sion cuffs were used to repair the transection in one patient.
No treatment delay occurred because of device unavailabil-
ity in our institution. All patients were systemically hepa-
rinized with 80 U/kg and then reversed at the completion
of the procedure. Prophylactic spinal drainage was not
performed.
Patients underwent computed tomography (CT) an-
giography of the chest and four-view plain chest radiogra-
phy before discharge from the hospital, at 1 month, and
then yearly with an office visit. Follow-up information for
these patients was obtained from clinic records, and CT
scans were reviewed to assess for complications such as
endoleak, migration, or collapse.
RESULTS
Ten patients (5 men and 5 women) underwent thoracic
endovascular aortic repair (TEVAR) for TAT during the
study period. Mean age was 44 years (range, 20 to 84
years). Motor vehicle accidents accounted for seven tran-
sections, a snowmobile accident accounted for one, a sky-
diving injury accounted for another, and an iatrogenic
injury during balloon angioplasty for an aortic coarctation
for the last. Other associated injuries are detailed in Table I.
Time from injury to treatment varied greatly in this
series. Treatment was acute in seven patients, defined here
as 24 hours of injury. Late transfer from a referring
hospital and a false-negative initial CT scan resulted in
Table I. Associated injuries
Patient Associated injury
1 None
2 Diaphragmatic rupture, pneumothorax, rib fract
3 Rib fractures
4 Pelvic fracture
5 Liver laceration, jejunal perforation, gastric
perforation, pelvic fracture
6 Hemothorax, hemoperitoneum, femur fracture
7 Diaphragmatic rupture, splenic laceration
8 Liver laceration, pelvic fracture, pulmonary
contusion, ileal perforation
9 Liver/splenic laceration, pelvic fracture, tibia fra
10 Liver laceration, pelvic fracture, femur fracturedelayed subacute TEVAR in two patients, at 4 and 6 daysafter injury, respectively. In another patient with a stable
aortic transection and a severe liver laceration with pelvic
hemorrhage, TEVAR was delayed by 2 months at the
discretion of the referring physician (Table I).
Four patients underwent operations for other acute
life-threatening injuries before repair of their aortic transec-
tion (Table I). These operations included an exploratory
laparotomy in three patients and open reduction and fixa-
tion of an open long-bone fracture in one patient.
The diagnosis of TAT was made by CT in all patients.
The location of injury was at the expected anatomic loca-
tion, within 1 to 3 cm of the aortic isthmus, in all patients.
A Gore TAG Thoracic Endoprosthesis was used in eight
patients and a Cook Zenith TX2 TAA Endovascular Graft
in one. TwoGore Excluder extension cuffs were used in the
repair of the patient with the iatrogenic TAT. The repair in
two patients was in the context of a clinical investigational
protocol, and the rest represented off-label usage of these
devices.
Average aortic diameter at the isthmus was 25 mm
(range, 23 to 29 mm), and stent graft diameters were 26 to
30 mm, with lengths of 3 cm for the extension cuffs to 15
cm for the longer thoracic stent grafts. Mean external iliac
diameter of these patients was 10 mm (range, 7 to 15 mm).
No conduits were required (Table II).
Completion angiography revealed no endoleaks or
other graft-related complications; however, one patient did
have a small proximal type 1 leak at the lesser curve of the
arch on predischarge CT that resolved by the 1-month
follow-up. This patient accounts for an immediate technical
success rate of 90%. There were no 30-day deaths.
In eight cases, the stent graft was deployed distal to the
left subclavian artery origin. The stent graft intentionally
covered the left subclavian artery origin in two patients, and
no sequelae developed as a result. No patient presented
with a spinal cord ischemic injury or stroke. There were no
groin complications or iliac artery injuries. At a mean of 20
months of follow-up, all patients are doing well (Table II).
A late graft-related complication occurred in a 50 year-
old man whose endograft collapsed 5 months after repair.
His aortic transection resulted from a skydiving accident









Reduction and fixation of tibia 6 d
None 2 monures
cture(Fig, A). At the initial repair, he was treated with a 26-mm
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diameter measured 23 mm (Fig, B). The completion an-
giogram showed a small but appreciable bird’s beak with-
out an endoleak (Fig, C). A CT scan at 3 months revealed
that the bird’s beak was still present, with no endoleak or
graft collapse. At 5 months from the initial repair, he
experienced new onset of chest pain and was diagnosed
with a recurrent pseudoaneurysm at the site of the original
TAT secondary to endograft collapse (Fig, D). This was
managed by a secondary extension graft. Because the trans-
verse arch proximal to the left subclavian artery measured
25 mm in diameter, a 28-mm  15-cm TAG device was
deployed with coverage of the left subclavian artery origin
(Fig, E). However, 1 month after the placement of this
second stent graft, the patient presented with sepsis related
to aortoesophageal fistula. He ultimately underwent esoph-
agectomy, excision of the stent grafts, and open aortic
replacement; fortunately, he recovered and now is doing
well. This patient accounts for an overall late graft-related
complication rate of 10%.
DISCUSSION
Traditional open repair of TAT involving thoracotomy,
aortic cross-clamping, and in some cases left heart bypass is
a highly invasive and morbid procedure. Respiratory com-
promise from lung and chest wall injuries is compounded
by thoracotomy, and aortic cross-clamping and unclamp-
ing complicate pre-existing hemodynamic and cardiac in-
stability in these critically injured patients. Paraplegia, the
most feared complication of any elective thoracic aortic
procedure, becomes an even more significant problem in
the emergency setting of trauma.
For these reasons, up to a third of trauma patients who
arrive at a hospital alive with TAT die before they are
deemed fit for open aortic surgery.12 The mortality rates for
Table II. Operative variables and complications
Variable* Value
Gore TAG† 8
Gore Excluder extension cuffs† 1
Cook TX2‡ 1
Mean aortic diameter, mm (range) 25 (23-29)
Stent graft diameter range, mm 26-30
Mean external iliac diameter, mm (range) 10 (7-15)
Left subclavian covered 2
Left arm ischemia 0





Iliac injury or groin complication 0 (0)
Procedure related complication 1 (10)
Mortality 0 (0)
Mean follow up, mon (range) 20 (2-70)
*Data are presented as number (%) unless indicated otherwise.
†W.L. Gore & Associates, Flagstaff, Ariz.
‡Cook Inc, Cook Inc, Bloomington, Ind.those who do undergo operation approach 30%.5 A varietyof technical improvements, including the use of shunts for
distal perfusion and cardiopulmonary bypass, seem to have
decreased the mortality rate of this operation in some
cases13; but overall, open thoracic aortic surgery in these
trauma victims remains a daunting undertaking.
Delaying aortic repair in those who otherwise would
not tolerate immediate surgery is often the only alternative.
In fact, when this delay is judiciously applied, it may actually
improve survival after aortic surgery in selected cases where
immediate operation in a patient with other life-threatening
injuries would likely result in death.14,15 This delay, of
course, comes at a cost: some patients with untreated TAT
may progress to exsanguination before undergoing repair.3
The advent of TEVAR for the treatment of TAT prom-
ises to avoid many of the complications associated with
open thoracic aortic repair. It therefore may allow surgeons
to offer this treatment to more critically ill aortic transec-
tion patients that previously might not have tolerated open
repair and avoid having to delay repair of an injury that
leaves patients in a tenuous state while uncorrected.
Although TEVAR has only been approved for the
treatment of degenerative aneurysmal disease, applications
for other pathologies are emerging, including dissections
and TAT. Advantages of this application of TEVAR include
avoidance of thoracotomy, aortic cross-clamping, and left
heart or cardiopulmonary bypass, all major sources of mor-
bidity and death after open repair. In most cases, TEVAR
also requires considerably less time than open repair and
can be done expediently in relatively unstable patients.
Previously published studies of stent grafting for aortic
transection consist of case reports and small series, but all
consistently demonstrate that this application of TEVAR is
a feasible alternative to open repair. Reported immediate
technical success rate is virtually 100% in the literature, with
very low paraplegia rates.
Tehrani et al6 and Hoornweg et al7 published series of
30 and 28 patients, respectively, without incidence of
procedure-related death or paralysis.6,7 A series of 20 pa-
tients was recently published by Neschis et al,16 with results
similar to the present series. They reported one endoleak,
one graft collapse, and no procedure-related deaths, al-
though four patients in their series died from other injuries.
Amabile et al17 published a series of 20 patients with
TAT, of whom nine were treated with TEVAR and 11 with
open surgery, including direct repair or aortic replacement
and cardiopulmonary bypass. The technical success rate in
their endovascular group was 100%, without any procedure-
related death or morbidity, including paralysis, although
one patient died after an open surgery. They concluded that
the immediate outcome after endovascular aortic transec-
tion repair was at least as good as open repair.
The present series also demonstrated a high immedi-
ate technical success rate, with only one procedure-
related complication. During the same time period, 43
patients underwent open repair in our institution, eight
(18.6%) of whom died in the perioperative period. Care
should be taken in making this comparison, however,
because this is only a retrospective review of the TEVAR
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application of TEVAR for TAT in both the acute and
subacute stages of injury. Thus, endovascular repair of
traumatic transection seems to be a flexible treatment
option that can be used immediately after injury in
critically ill patients or in a delayed fashion in selected
patients.
However, as in the setting of endovascular repair for
degenerative thoracic aneurysms, potential complications
A, A 50-year-old man was found to have a thoracic a
underwent a successful thoracic endovascular aneurysm re
and Assoc, Flagstaff, Ariz).C, A computed tomography s
without endoleak or graft collapse. The superimposed “
however, presented at 5 months with a recurrent pseudoa
with repeat endografting with good initial result, but u
aortoesophageal fistula.unique to stent grafting must be taken into considerationwhen applying this technique to repair TAT. Type 1 and
type 2 endoleak associated with left subclavian coverage are
well documented in the literature as are the incidences of
stent graft collapse or migration.11,16,18-23 Although no
endoleaks were identified on completion arteriography in
the current study, a small type 1 endoleak was detected on
a postoperative CT scan that spontaneously resolved by the
1-month follow-up. The lone late graft-related complica-
tion in this series was indeed a stent graft collapse that
transection after a skydiving accident (arrow). B, He
ith a 26-mm 10-cmTAG endoprosthesis (W. LGore
t 3 months showed a small but appreciable “bird’s beak”
e” symbol outlines the “bird’s beak.” D, The patient,
sm due to endograft collapse (arrow).E,Hewas treated





ltimatresulted in serious complications.
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oversizing, a problem inherently associated with the smaller
aortic diameters of relatively young trauma victims. Indeed,
several cases of thoracic endograft collapse after TAT repair
have been reported.16,20-23 The mean aortic diameter of
patients with traumatic aortic injury was 19.3 mm in one
study24; however, currently available endografts in the
United States do not accommodate such small aortas. The
smallest TAG device accommodates a 23-mm aorta and the
smallest TX2 device a 24-mm aorta. Deploying these grafts
into a small aorta inevitably results in folding of the graft
material at the proximal edge and thus poor apposition.
In addition, the acute angle of the transverse arch
combined with poor conformability of the grafts causes a
“bird’s beak” phenomenon in reference to the elevation of
the proximal portion of the graft from the lesser curve of
the aorta. Vector forces exerted onto this area cause canti-
levering effects and may collapse the graft25 as observed in
our series. This patient did not receive an oversized device,
but did have a “bird’s beak” on completion angiogram and
on a CT at 3 months. Anecdotally, it was thought that the
collapses occur early after implantation, but a review of the
literature suggests that the timing of collapse is highly
variable, ranging from days to 6 months. The timing noted
in this series falls within the reported range.
Because the left subclavian artery is close to the tran-
section, it often must be covered for an adequate proximal
sealing zone. Although this is innocuous in most cases, it
should be avoided in certain situations, such as left internal
mammary-to-coronary bypass, left axillary-to-femoral by-
pass, or in the setting of a dominant left vertebral artery.
Left subclavian coverage in the setting of prior aortic sur-
gery may also increase the risk of postoperative spinal cord
ischemia. In such cases, left subclavian artery revasculariza-
tion should be performed to preserve the anterior spinal
artery and other collateral flow to the spinal cord.26,27
Smaller sizes of the aorta and external iliac arteries in
this relatively young group of patients may also cause access
vessel injury or, as already mentioned, crimping of the graft
when deployed. Some authors9,28,29 have thus recom-
mended aortic extension cuffs designed for use in the
infrarenal aorta as a smaller diameter alternative to thoracic
devices designed for an aneurysm. The short lengths of
these cuffs, however, often require multiple segments to
provide enough coverage, predisposing to type 3 en-
doleaks.
Systemic heparinization was used in all patients in this
study for the short duration of time that the access sheaths
were in place to prevent lower extremity arterial thrombo-
sis, and it was reversed at the completion of the procedure.
This did not contribute to overall significant blood loss in
this series. TEVAR without heparinization has been report-
ed6,7 and would be indicated in the management of TAT
with intracranial bleeding or other hemorrhagic injuries.
The need for rigorous long-term follow-up, including
multiple CT scans, can be an issue in this patient population
with traditionally poor follow-up rates. Finally, the long-
term durability of these stent grafts in patients who aretypically only in their third or fourth decade of life will need
to be established before TEVAR can completely replace
open aortic repair for TAT. In that regard, TEVAR may
serve a role of a bridge graft in the management of TAT as
a temporizing measure for those who develop persistent
pseudoaneurysm or other graft-related complications. We
do not yet espouse routine open conversion after TEVAR.
CONCLUSION
TEVAR promises to be a viable alternative to open
surgical repair in a variety of the situations that trauma
patients often face. It can be performed with less risk of
exacerbating pulmonary injuries than a thoracotomy and
can be completed more expeditiously in unstable patients
than open repair. Furthermore, as demonstrated by the
current series, delayed repair can be done safely and effec-
tively in selected patients with TAT. Continued surveillance
is needed to define long-term outcomes in this group of
young patients.
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